权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Investigating the role of C9orf72 in autophagic and metabolic dysregulation in ALS/FTD

研究 C9orf72 在 ALS/FTD 自噬和代谢失调中的作用

基本信息

批准号：
9904831
负责人：
Jiou Wang
金额：
$ 56.75万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-05-15 至 2024-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9904831
关键词：
Address Aging Alzheimer&apos s Disease Amyotrophic Lateral Sclerosis Autophagocytosis Biochemical Biological Models Brain C9ORF72 Caenorhabditis elegans Cells Clinical Defect Dementia Disease Equilibrium Etiology FRAP1 gene Feedback Frontotemporal Dementia Genes Genetic Genetic study Goals Guanosine Triphosphate Phosphohydrolases Homeostasis Huntington Disease Intervention Investigation Knowledge Lead Light Link Lysosomes Metabolic Metabolic Control Metabolic Pathway Metabolism Molecular Molecular Genetics Motor Neurons Mutation Nerve Degeneration Neurodegenerative Disorders Nucleotides Organelles Pathogenesis Pathology Pathway interactions Patients Physiological Play Predisposition Proteins Public Health Quality Control Regulation Research Role Signal Transduction Societies Spinal Cord System Temporal Lobe Tissues Toxic effect Untranslated RNA Work base cell growth regulation coactivator-associated arginine methyltransferase 1 effective therapy epigenetic regulation frontal lobe frontotemporal lobar dementia-amyotrophic lateral sclerosis genetic approach insight lipid metabolism loss of function neurotoxicity news novel novel strategies novel therapeutic intervention tool treatment strategy

项目摘要

Neurodegeneration is an increasing public health issue and remains an unsolved biomedical challenge. Genetic discoveries have provided news avenues for investigating the molecular mechanisms of several neurodegenerative diseases. Recently, a hexanucleotide repeat expansion in a noncoding region of the C9orf72 gene was linked to the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is characterized by loss of motor neurons, and the C9orf72 mutation represents the most common genetic cause of both familial and sporadic ALS. FTD is characterized by degeneration of the frontal and temporal lobes of the brain and is the second most common type of dementia for people older than 65; the C9orf72 mutation is also the most common genetic causes for FTD. The C9orf72 mutation is also found to contribute to Alzheimer’s disease and Huntington’s disease. Despite intense efforts and rapid advances, our understanding of the disease mechanisms and treatment strategies for C9orf72-linked ALS/FTD are still at the early stages. To help relieve the public health burden associated with these diseases, it is important to understand the mechanisms underlying the pathogenesis. We have recently discovered that C9orf72 plays an important role in the regulation of autophagy and related metabolic processes, suggesting that further studies of C9orf72 functions could shed light on the mechanism of ALS/FTD pathogenesis. The goal of the proposed project is to elucidate the mechanisms through which dysregulation of C9orf72 functions leads to molecular defects and neuronal toxicity. The specific aims are to identify the central mechanisms through which C9orf72 regulates autophagy and related metabolism, to delineate the pathways through which the pathogenesis is generated, and to identify potential intervention strategies. The proposed studies, which combine biochemical, molecular, and genetic approaches, are expected to provide insight into fundamental mechanisms of neurodegeneration in ALS/FTD that may ultimately leads to novel approaches for treating these devastating neurodegenerative diseases.

神经退行性疾病是一个日益严重的公共卫生问题，并且仍然是一个尚未解决的问题生物医学挑战。基因发现为调查这一问题提供了新闻途径几种神经退行性疾病的分子机制。最近，六核苷酸 C9orf72 基因非编码区的重复扩增与神经退行性疾病肌萎缩侧索硬化症 (ALS) 和额颞叶痴呆（FTD）。 ALS 的特点是运动神经元丧失，C9orf72 突变代表家族性和散发性 ALS 的最常见遗传原因。 FTD 的特点是大脑额叶和颞叶的退化是第二常见的 65 岁以上人群的痴呆症类型； C9orf72 突变也是最常见的 FTD 的遗传原因。 C9orf72 突变也被发现与阿尔茨海默病有关和亨廷顿舞蹈症。尽管付出了巨大的努力并取得了快速的进步，但我们对 C9orf72相关的ALS/FTD的疾病机制和治疗策略仍处于早期阶段阶段。为了帮助减轻与这些疾病相关的公共卫生负担，重要的是了解发病机制的基础。我们最近发现 C9orf72在自噬及相关代谢过程的调节中发挥重要作用，表明对 C9orf72 功能的进一步研究可以揭示其机制 ALS/FTD 发病机制。拟议项目的目标是阐明机制 C9orf72 功能失调会导致分子缺陷和神经元缺陷毒性。具体目标是确定 C9orf72 的核心机制调节自噬和相关代谢，以描绘自噬的途径产生发病机制，并确定潜在的干预策略。拟议的结合生化、分子和遗传学方法的研究预计将深入了解 ALS/FTD 神经退行性变的基本机制，可能最终导致治疗这些破坏性神经退行性疾病的新方法。